References
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.
- Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–756.
- Gilboa SM, Devine OJ, Kucik JE, et al. Congenital heart defects in the United States: Estimating the magnitude of the affected population in 2010. Circulation. 2016;134(2):101–109.
- Thompson JL, Kuklina EV, Bateman BT, et al. Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol. 2015;126(2):346–354.
- Schlichting LE, Insaf TZ, Zaidi AN, et al. Maternal comorbidities and complications of delivery in pregnant women with congenital heart disease. J Am Coll Cardiol. 2019;73(17):2181–2191.
- Elkayam U, Goland S, Pieper PG, et al. High-Risk cardiac disease in pregnancy: part I. J Am Coll Cardiol. 2016;68(4):396–410.
- Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303–2311.
- Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–2132.
- Hayward RM, Foster E, Tseng ZH. Maternal and fetal outcomes of admission for delivery in women with congenital heart disease. JAMA Cardiol. 2017;2(6):664–671.
- Moghbeli N, Pare E, Webb G. Practical assessment of maternal cardiovascular risk in pregnancy. Congenit Heart Dis. 2008;3(5):308–316.
- The Centers for Disease Control and Prevention. Pregnancy mortality surveillance system [accessed 2021 Aug 10]. Available from: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm
- Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–467.
- Kuklina E, Callaghan W. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. BJOG. 2011;118(3):345–352.
- Klebanoff MA, Snowden JM. Historical (retrospective) cohort studies and other epidemiologic study designs in perinatal research. Am J Obstet Gynecol. 2018;219(5):447–450.
- Healthcare Cost and Utilization Project. Overview of the national (nationwide) inpatient sample [accessed 2021 Feb 20]. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp
- Healthcare Cost and Utilization Project. Trend weights for HCUP NIS data [accessed 2021 Mar 20]. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp
- The Healthcare Cost and Utilization Project. NIS description of data elements [accessed 2021 Feb 20]. Available from: https://www.hcup-us.ahrq.gov/db/vars/dxn/nisnote.jsp
- Centers for Medicare & Medicaid Services. ICD-10 data [accessed 2021 Mar 20]. Available from: https://www.cms.gov/Medicare/Coding/ICD10/
- Kinlaw AC. alankinlaw/Easy_ICD9-to-10_GEMs_mapping [published 2019 Sept 24; accessed 2021 May 31]. Available from: https://github.com/alankinlaw/Easy_ICD9-to-10_GEMs_mapping.
- Kuklina E, Whiteman M, Hillis S, et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J. 2008;12(4):469–477.
- Clapp MA, James KE, Friedman AM. Identification of delivery encounters using international classification of diseases, tenth revision, diagnosis and procedure codes. Obstet Gynecol. 2020;136(4):765–767.
- The Centers for Disease Control and Prevention. Severe maternal morbidity in the United States [accessed 2021 February 20]. Available from: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/severematernalmorbidity.html
- Main EK, Abreo A, McNulty J, et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol. 2016;214(5):643 e641–643 e610.
- National Cancer Institute. Joinpoint trend analysis software [published 2020; accessed 2021 March 20]. Available from: https://surveillance.cancer.gov/joinpoint/
- Barrio G, Pulido J, Bravo MJ, et al. An example of the usefulness of joinpoint trend analysis for assessing changes in traffic safety policies. Accid Anal Prev. 2015;75:292–297.
- National Cancer Institute. Average annual percent change (AAPC) and confidence interval [accessed 2021 Apr 1]. Available from: https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/apc-aapc-tau-confidence-intervals
- Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statist Med. 2000;19(3):335–351.
- Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200.
- Yang D, Dalton J. A unified approach to measuring the effect size between two groups using SAS. SAS Global Forum [published 2012; accessed 2021 Apr 14]. Available from: http://support.sas.com/resources/papers/proceedings12/335-2012.pdf
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies [accessed 2021 Mar 28]. Available from: https://www.equator-network.org/reporting-guidelines/strobe/
- Ramage K, Grabowska K, Silversides C, et al. Association of adult congenital heart disease with pregnancy, maternal, and neonatal outcomes. JAMA Netw Open. 2019;2(5):e193667–e193667.
- Elkayam U, Goland S, Pieper PG, et al. High-Risk cardiac disease in pregnancy: part II. J Am Coll Cardiol. 2016;68(5):502–516.
- Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College Of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(12):e81–e192.
- Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645.
- Canobbio MM, Warnes CA, Aboulhosn J, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the american heart association. Circulation. 2017;135(8):e50–e87.
- Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College Of Obstetricians And Gynecologists. Circulation. 2018;137(24):e843–e852.
- Grodzinsky A, Florio K, Spertus JA, et al. Importance of the cardio-obstetrics team. Curr Treat Options Cardiovasc Med. 2019;21(12):84.